Figure 2

Comparison of the number of cases associated with cellular tumor stroma (a) and inflammatory cells (b) in breast carcinomas classified as low vs intermediate/high risk for distant recurrence by Oncotype DX Recurrence Score (RS) and Mammostrat Prognostic Index (PI), respectively. ***P<0.0001; NS, not significant, Chi-square test.